|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$2.93 |
$3.03 |
$2.79 |
$2.80 |
141.30K | 03/22/2024 |
$2.80 |
$2.93 |
$2.78 |
$2.91 |
68.80K | 03/25/2024 |
$2.89 |
$2.89 |
$2.71 |
$2.76 |
167.50K | 03/26/2024 |
$2.76 |
$2.83 |
$2.69 |
$2.72 |
88.70K | 03/27/2024 |
$2.70 |
$2.84 |
$2.66 |
$2.82 |
160.20K |
|
Oramed Pharmaceuticals is a pharmaceutical company. Co. is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Co.'s primary product, ORMD-0801, is an orally ingestible insulin capsule for the treatment of diabetes. In addition to its key product, the ORMD-0801 insulin capsule, Co. is using its technology for an orally ingestible Glucagon-like peptide-1 capsule, or ORMD-0901. Co. is developing a drug candidate, a weight loss treatment in the form of an oral leptin capsule. | |
|
Oramed Pharmaceuticals (ORMP) has the following price history information. Looking back at ORMP historical stock prices for the last five trading days, on March 21, 2024, ORMP opened at $2.93, traded as high as $3.03 and as low as $2.79, and closed at $2.80. Trading volume was a total of 141.30K shares. On March 22, 2024, ORMP opened at $2.80, traded as high as $2.93 and as low as $2.78, and closed at $2.91. Trading volume was a total of 68.80K shares. On March 25, 2024, ORMP opened at $2.89, traded as high as $2.89 and as low as $2.71, and closed at $2.76. Trading volume was a total of 167.50K shares. On March 26, 2024, ORMP opened at $2.76, traded as high as $2.83 and as low as $2.69, and closed at $2.72. Trading volume was a total of 88.70K shares. On March 27, 2024, ORMP opened at $2.70, traded as high as $2.84 and as low as $2.66, and closed at $2.82. Trading volume was a total of 160.20K shares.
ORMP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Oramed Pharmaceuticals shares, starting with a $10,000 purchase of ORMP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$11.80 |
|
End price/share: |
$2.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-76.10% |
|
Average Annual Total Return: |
-13.34% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,389.78 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $2.80 | 03/22/2024 | $2.91 | 03/25/2024 | $2.76 | 03/26/2024 | $2.72 | 03/27/2024 | $2.82 |
|
|